Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human GPC5 Antibodies:
anti-Mouse (Murine) GPC5 Antibodies:
anti-Rat (Rattus) GPC5 Antibodies:
Go to our pre-filtered search.
Human Monoclonal GPC5 Primary Antibody for CyTOF, FACS - ABIN4899914
Williamson, Selfe, Gordon, Lu, Pritchard-Jones, Murai, Jones, Workman, Shipley: Role for amplification and expression of glypican-5 in rhabdomyosarcoma. in Cancer research 2007
Show all 2 Pubmed References
Taken together, our results suggest GPC5 as a tumor suppressor in PDAC and its expression is possibly regulated by miR (show MLXIP Antibodies)-4295. Our study indicates that the miR (show MLXIP Antibodies)-4295/GPC5 axis may play an important role in the pathogenesis of PADC and has potential applications for the development of PDAC therapy.
Suggest that GPC5 is able to suppress the lung adenocarcinoma metastasis by competitively binding to Wnt3a (show WNT3A Antibodies) and inactivating the Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling pathway.
GPC5 is a novel epigenetically silenced tumor suppressor, which inhibits tumor growth by suppressing Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling in lung adenocarcinoma.
GPC5 protein expression showed a close correlation with the tumorigenesis and tumor progression of prostate cancer, and that might be applied as a novel biomarker for the prediction of diagnosis and prognosis of prostate cancer.
These results suggest that miR (show MLXIP Antibodies)-297 acted as an oncogenic miRNA, partly by targeting GPC5, adenocarcinoma of the lung.
Results suggest a potential association between CRP and GPC5 variants with lung cancer risk; variation in GKN1 is associated with chemotherapy response in the Chinese Han population.
miR (show MLXIP Antibodies)-709 may positively regulate invasion and metastasis of hepatocellular carcinoma through targeting GPC5.
gene variants in IRF5 (show IRF5 Antibodies), IRF8 (show IRF8 Antibodies) and GPC5 were not associated with risk of relapse or disease progression in multiple sclerosis
GPC5, a tumor suppressor, is regulated by miR (show MLXIP Antibodies)-620 in lung adenocarcinoma.
Variants in the 50-upstream region of GPC5 confer risk of lung cancer in never smokers
The findings elucidate the pivotal role of GPC5, identified as a susceptible gene in the genome-wide association study, in hyperglycemia-induced glomerulopathy.
Shh (show SHH Antibodies) binds to HSPG (show SDC2 Antibodies) co-receptors containing a glypican 5 core and 2-O-sulfo-iduronic acid to promote neural precursor proliferation.
Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation.
, glypican proteoglycan 5